PAC-935

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePAC-935
Drug Alias NamePAC-935
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHepatitis CHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPacgen Life Science
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPacgen Life Science
Active IndicationsN/A
Inactive IndicationsHepatitis CHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A